News How Researchers are Returning Sensation to Mastectomy Patients The Bionic Breast Project is an interdisciplinary research program applying bionic technologies to restore post-mastectomy breast function. Leading the project is Stacy Lindau, MD, MA ’02, a Professor of Obstetrics...
Technology Algorithm And System For Accurate Breast Parenchymal Enhancement Calculation By Digital Lesion Removal A method uses AI and clustering to remove lesions from breast MRI images, reconstructing clearer projection images for more accurate assessment of tissue enhancement and improved breast cancer risk evaluation.…
News Novel Breast Cancer Therapy Shows Promise Moving a basic scientific finding from a lab to the clinical setting is the Holy Grail for medical researchers the world over. Suzanne Conzen, MD, professor of hematology/oncology at the...
Technology A Prognostic Gene Signature for Predicting Chemotherapy Sensitivity and Patient Survival in ER-negative Breast Cancer ER-negative (ER-) breast cancers make up 20% of all breast cancer diagnosis. However, no gene signature exists for predicting drug sensitivity and prognosis. Therefore, the clinical standard remains treating patients…
News UChicago Grad Student Named ‘Changemaker,’ Awarded Grant to Support Bionic Breast Project A graduate student in Sliman Bensmaia’s lab at the University of Chicago, Katie Long, MD/PhD ’24, has received $20,000 from Aerie to support her research into breast sensation. The intimate...
News Patent of the Week: Identifying High-Risk Triple Negative Breast Cancer Patients Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer and has the least favorable prognosis, as there are fewer targeted medicines available. Accounting for about 10-20%...
Technology IRDS: Predictive 7-gene Signature for Breast Cancer Therapy After surgical removal of breast cancer tumors, adjuvant chemotherapy and radiation therapy have an absolute survival benefit of just 5-10%. Currently approved breast cancer diagnostics do not predict patient responses…
News Patent of the Week: A Low Dose, Multi-Drug Cocktail for Breast Cancer Treatment More than 150,000 breast cancer survivors were living with metastatic disease, three-fourths of whom were originally diagnosed with stage I-III, as of January 1, 2019, according to the American Cancer...
Technology A Low Dose, Multi-drug Cocktail for the Treatment of Metastatic and Resistant Breast Cancers An estimated 20-30% of breast cancer patients suffer from metastatic recurrence, which can be perpetuated by an overreliance on high doses of a single drug during initial treatment. In addition…
Technology Novel Small Molecules For Treatment Of Breast and Ovarian Cancer According to the National Osteoporosis Foundation (NOF) approximately 10.2 million adults in the United States have osteoporosis, with an additional 43.4 million having low bone mass. One in eight women…
News Patent of the Week: A Predictive Gene Signature for Breast Cancer Therapy Inventors, including University of Chicago researcher Edwardine Labay, have patented a seven-gene signature that can be used to assess the risk of breast cancer progression and treatment response. The invention...
News 3 Novel Disease-Fighting Technologies You Should Know About Ahead of BIO 2022 Researchers at the University of Chicago have developed methods to increase the clinical efficacy of immunotherapies, provide long-lasting immune tolerance for autoimmune or transplantation therapy, and treat breast and ovarian...
